Discover trends, market shifts, and competitive outlooks for the biologics outsourcing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Biologics Outsourcing Market From 2025 To 2029?

The size of the biologics outsourcing market has experienced rapid expansion lately. The market is projected to inflate from $20.06 billion in 2024 to $22.7 billion the following year with a Compound Annual Growth Rate (CAGR) of 13.2%. Factors such as rising R&D costs, regulatory pressures, the need for specialized skill sets, and the effects of globalization have contributed to this historical growth.

In the coming years, the biologics outsourcing market is projected to witness rapid expansion, with its worth expected to reach $37.52 billion by 2029, growing at a compound annual growth rate (CAGR) of 13.4%. Factors influencing this growth during the anticipated period include emerging market expansion, personalized medical treatment advancements, strategic partnerships, and expiration of biological drug patents. Key trends expected during this period encompass technological advancements, increased intricacy in outsourcing, biosimilars market growth, integration of data analytics, and enhanced supply chain resilience.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12573&type=smp

Which Factors and External Forces Are Driving Demand in the Biologics Outsourcing Market?

The acceleration in the number of cancer instances is anticipated to drive the expansion of the biologics outsourcing market. Cancer encompasses a wide spectrum of diseases that can originate in virtually any organ or tissue of the body when errant cells multiply inexorably, transgress their typical limits, and either disseminate to other organs or infiltrate adjacent bodily parts. Biologics outsourcing contributes substantially to cancer scenarios by offering specialized skills, resources, and infrastructure for the evolution, production, and clinical supply of biologic therapies, such as monoclonal antibodies, immunotherapies, and other targeted biologics employed for the diagnosis, cure, and control of diverse cancer types. For example, in January 2023, the National Center for Biotechnology Information, a US governmental agency, reported 1,958,310 fresh cancer instances in the US, and 609,820 cancer fatalities are estimated to take place in 2023. Moreover, the number of new cancer instances annually is predicted to increase to 29.5 million, and the number of cancer-linked fatalities to climb to 16.4 million by 2040. Hence, the escalating number of cancer instances is fostering the expansion of the biologics outsourcing market.

Which Segments in the Biologics Outsourcing Offer the Most Growth?

The biologics outsourcing market covered in this report is segmented –

1) By Product Type: Antibodies, Recombinant, Vaccines, Protein, Other Products

2) By Source: Human, Microbial, Other Source

3) By Application: Oncology, Cellular And Gene Therapy, Blood And Blood-Related Products Development, Vaccine Development, Stem Cell Research, Other Applications

4) By End User: Pharmaceutical Industries, Biotechnology Industries, Contract Development And Manufacturing Organization(CDMO)

Subsegments:

1) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies

2) By Recombinant: Recombinant Proteins, Recombinant DNA Products

3) By Vaccines: Therapeutic Vaccines, Preventive Vaccines

4) By Protein: Enzymes, Hormones, Cytokines

5) By Other Products: Gene Therapies, Cell Therapies, Biosimilars

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12573&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Biologics Outsourcing Market?# Market?

North America was the largest region in the biologics outsourcing market in 2024. The regions covered in the biologics outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Cutting-Edge Market Trends Are Expected to Drive theBiologics Outsourcing Market’s Growth?

A rising trend in the biologics outsourcing market is the technological advancements in the field of biologics. To maintain a competitive edge, leading companies in the market are embracing these new technologies. For instance, in February 2022, Abzena, Alira Health, and Oncodesign collaborated to establish DRIVE-Biologics. This consortium focuses on biologic drug discovery and development programs, offering specialized services from biological discovery to clinical and commercial manufacturing. This joint initiative merges industry expertise in areas like design, preclinical pharmacology proof of concept and pharmaco-imaging, toxicology, and clinical design through to commercial manufacturing. As a result, it streamlines sharing of information and timely delivery of program outcomes to lower the risks associated with biologics development. Furthermore, partners can tap into expert knowledge at any stage of the drug development and discovery process, including design, preclinical, clinical, and CMC (chemistry, manufacturing, and control).

View the full report here:

https://www.thebusinessresearchcompany.com/report/biologics-outsourcing-global-market-report

What Are the Key Elements That Define the Biologics Outsourcing Market?

Biologics outsourcing refers to pharmaceutical companies partnering with external vendors or contract manufacturing organizations (CMOs) to outsource various aspects of biologic drug development, manufacturing, and supply chain management. This is used in the pharmaceutical industry for different purposes related to biological drug development, manufacturing, and supply chain management.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12573

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model